University of California, Davis researchers have developed a new, neuroplasticity-promoting drug closely related to LSD that ...

Pfizer is stopping development of its experimental oral GLP-1 drug for obesity, the company announced Monday, after a patient ...

A study by scientists at the Herbert Irving Comprehensive Cancer Center (HICCC) introduces a more cost-effective, scalable ...

Researchers have developed a new, neuroplasticity-promoting drug closely related to LSD that harnesses the psychedelic's therapeutic power with reduced hallucinogenic potential.

For adults struggling with weight, a weekly injection of tirzepatide offers real hope. Recent findings presented at the ...

University of California, Davis, researchers have developed a new, neuroplasticity-promoting drug closely related to LSD that ...

A new type of antibiotic for treatment of urinary tract infections in women could also work against gonorrhea infections, a ...

Research highlights the potential for modifying the chemical structures of psychedelics to produce analogues with improved ...

Sandoz sues Amgen in U.S. court over Enbrel patents, alleging efforts to block biosimilar Erelzi and delay competition in the ...

A new Canadian guideline urges lifestyle interventions for obese children but also says today's new drugs might help kids ...

A team at UC Davis has created a new drug called JRT that mimics LSD’s brain-healing effects without the hallucinogenic side effects. By flipping just two atoms in LSD’s structure, researchers made a ...

Neuren Pharmaceuticals and its US partner Acadia have been blitzing it with the Rett syndrome treatment Daybue.